Current through Register Vol. 47, No. 22, November 25, 2024
Section 1 CCR 301-68-5.00 - Use of Stock Epinephrine Auto-injectors in Emergency Situations in School Settings5.01 A local school board may adopt and implement a policy permitting its schools to acquire and maintain a stock supply of epinephrine auto-injectors for use in emergency anaphylaxis events that occur on school grounds.5.02 For local school boards that elect to adopt such a policy, the school district shall meet the following requirements: 5.02(a) The school district must have a Standing Order and Protocol regarding the administration of epinephrine auto-injectors. The Standing Order and Protocol shall include the dosage of epinephrine, indications for use, route of medication and follow-up procedures. Standing Orders must be renewed annually and with any change in prescriber.5.02(b) Building level administrators in consultation with the School Nurse shall identify at least two employees who are CPR/1 st Aid certified to be trained and delegated in the administration of stock epinephrine auto-injectors ("Designated Personnel"). Schools with larger populations are encouraged to train additional staff as Designated Personnel.5.02(c) Training of Designated Personnel must be conducted by a School Nurse or Healthcare Practitioner using a state approved course. Training must include the components identified in Section 3.02 and shall also include: defining anaphylaxis, recognizing symptoms of anaphylaxis, understanding standards and procedures for storage, the correct methods for administering an epinephrine auto-injector, and follow up procedures. Such training and delegation are encouraged to be conducted on an annual basis5.02(d) Delegation by the school nurse or healthcare practitioner, in accordance with state legislation and rules concerning his or her practice, may only occur after Designated Personnel have received the training described in Section 5.02(c).42 CR 03, February 10, 2019, effective 3/2/201942 CR 03, February 10, 2019, effective 3/2/201945 CR 03, February 10, 2022, effective 3/17/2022